Bone Disease, Metabolic
7
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
Metabolic Profile of Bone in Professional Athletes
Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women
Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia
Diagnosis of Osteogenesis Imperfecta in Children
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant